Clinical evidence - Non-metastatic prostate cancer

被引:0
|
作者
Wilt, TJ
Brawer, MK
机构
[1] NW Prostate Inst, Seattle, WA 98133 USA
[2] Minneapolis VA Hosp, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
来源
WESTERN JOURNAL OF MEDICINE | 1999年 / 171卷 / 02期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article comes from Clinical Evidence, a new resource for clinicians, produced jointly by the BMJ Publishing Group and the American College of Physicians-American Society of Internal Medicine. Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical interventions gleaned from thorough searches and appraisal of the world literature. The first issue is available in book form in the United Kingdom, with a United States version planned for publication in October. The second issue, updated and expanded to cover more topics and questions, will be published 6 months later. Please see the advertisement For more information or visit our web site at www.evidence.org.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 50 条
  • [31] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Soum D. Lokeshwar
    Zachary Klaassen
    Fred Saad
    Nature Reviews Urology, 2021, 18 : 433 - 442
  • [32] Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
    M T Schweizer
    J Lin
    A Blackford
    A Bardia
    S King
    A J Armstrong
    M A Rudek
    S Yegnasubramanian
    M A Carducci
    Prostate Cancer and Prostatic Diseases, 2013, 16 : 357 - 361
  • [33] Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
    Schweizer, M. T.
    Lin, J.
    Blackford, A.
    Bardia, A.
    King, S.
    Armstrong, A. J.
    Rudek, M. A.
    Yegnasubramanian, S.
    Carducci, M. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) : 357 - 361
  • [34] VALIDATION OF STAMPEDE CRITERIA FOR NON-METASTATIC PROSTATE CANCER - AN EMPACT STUDY
    Joniau, Steven
    Chys, Brecht
    Briganti, Alberto
    Chlosta, Piotr
    De Meerleer, Gert
    Everaerts, Wouter
    Gontero, Paolo
    Graefen, Markus
    Gratzke, Christian
    Karnes, R. Jeffrey
    Marchioro, Giansilvio
    Sanchez-Salas, Rafael
    Spahn, Martin
    Tombal, Bertrand
    Van der Poel, Henk
    Van Poppel, Hein
    JOURNAL OF UROLOGY, 2018, 199 (04): : E203 - E204
  • [35] Suicide and accidental deaths among patients with non-metastatic prostate cancer
    Dalela, Deepansh
    Krishna, Nandita
    Okwara, James
    Preston, Mark A.
    Abdollah, Firas
    Choueiri, Toni K.
    Reznor, Gally
    Sammon, Jesse D.
    Schmid, Marianne
    Kibel, Adam S.
    Nguyen, Paul L.
    Menon, Mani
    Trinh, Quoc-Dien
    BJU INTERNATIONAL, 2016, 118 (02) : 286 - 297
  • [36] Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Zaina T. Al-Salama
    Drugs, 2019, 79 : 1591 - 1598
  • [37] Treatment and trials in non-metastatic castration-resistant prostate cancer
    Lokeshwar, Soum D.
    Klaassen, Zachary
    Saad, Fred
    NATURE REVIEWS UROLOGY, 2021, 18 (07) : 433 - 442
  • [38] Non-metastatic breast cancer
    Saglier, J
    JOURNAL DE CHIRURGIE, 2005, 142 (06): : 355 - 366
  • [39] Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2020, 15 (06) : 791 - 799
  • [40] Apalutamide for the Treatment of non-metastatic castration-resistant Prostate Cancer
    Miller, Kurt
    ONKOLOGE, 2019, 25 (03): : 275 - 276